Case Western Reserve University receives grant to investigate AML treatment for veterans

With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve University are investigating a new approach to treat Acute Myeloid Leukemia (AML) in military Veterans.

Cassava Sciences and former execs, facing SEC charges for misleading claims, agree to fines

Facing charges from the Securities and Exchange Commission for misleading claims related to a controversial Alzheimer’s drug candidate, Cassava Sciences and two of the company’s

September 27, 2024

Odevixibat by Ipsen for Biliary Atresia: Likelihood of Approval

Odevixibat is under clinical development by Ipsen and currently in Phase III for Biliary Atresia.

March 19, 2024

Lonnel Coats announces retirement from Lexicon; Another shakeup in Vir’s C-suite

→ Lexicon Pharmaceuticals CEO Lonnel Coats will retire July 7, 10 years to the day after accepting the job. Lexicon overcame numerous regulatory obstacles with

May 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.